Key result
Intramyocardial injections of a degradable ELRs-hydrogel led to a 16.2% average improvement in ejection fraction 21 days after intervention in an ovine model of non-transmural myocardial infarction.
Why the study?
Does elastin-like recombinamers-based hydrogel injection improve post-ischemic remodeling and functional recovery in a sheep model of non-transmural myocardial infarction?
Does elastin-like recombinamers-based hydrogel injection improve post-ischemic remodeling and functional recovery in a sheep model of non-transmural myocardial infarction?
Injection of an elastin-like recombinamers-based hydrogel improves functional recovery and cardiomyocyte preservation in a large animal model of myocardial infarction, suggesting potential for future clinical translation.
Answers are grounded in this paper and cite their sources.
May support hydrogel therapy for post-MI remodeling in large animals; leaves open human translation and should not change practice.
cardiomyocytes in the border zone of the infarct. We propose that our customized ECM favors cardiomyocyte preservation in the border zone by modulating the ischemic core and a marked functional recovery. The functional benefits obtained by the timely injection of the ELRs-hydrogel in a clinically relevant MI model support the potential utility of this treatment for further clinical translation.
No takes yet. Share an insight, caveat, or question.
Contessotto et al. (2021) studied Non-transmural myocardial infarction (NSTEMI) (n=39). Elastin-like recombinamers-based hydrogel (ELRs-hydrogel) vs. PBS injection or untreated (MI-only) was evaluated on Ejection fraction (EF) recovery 21 days after intervention (p=<0.01). Intramyocardial injections of a degradable ELRs-hydrogel led to a 16.2% average improvement in ejection fraction 21 days after intervention in an ovine model of non-transmural myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: